Suchergebnisse - "Lad, Deepesh"

PubPharm (7)

1

High-dose hydroxyurea with differentiating agents for treating ultra-high-risk acute promyelocytic leukemia in resource-challenged settings

enthalten in: Acta oncologica (Stockholm, Sweden) | 2022

von Singh, C. | Wadhera, S. | Yanamandra, U. | +15

2

A systematic review of economic evaluations of treatment regimens in multiple myeloma

enthalten in: Expert review of pharmacoeconomics & outcomes research | 2021

von Asrar, M. | Lad, D. | Prinja, S. | +1

3

Establishment of a comprehensive chronic lymphocytic leukemia clinic at a tertiary referral center in India

enthalten in: Blood advances | 2018

von Lad, D. | Tejaswi, V. | Malhotra, P. | +7

4

Variation in Adherence Measures to Imatinib Therapy

enthalten in: Journal of global oncology | 2018

von Yanamandra, U. | Malhotra, P. | Sahu, K. | +12

5

Global Burden of Multiple Myeloma : A Systematic Analysis for the Global Burden of Disease Study 2016

enthalten in: JAMA oncology | 2018

von Cowan, A. | Allen, C. | Barac, A. | +27

CommentIn: JAMA Oncol. 2019 Jan 1;5(1):116. - PMID 30489600

6

Long-term mucocutaneous adverse effects of imatinib in Indian chronic myeloid leukemia patients

enthalten in: International journal of dermatology | 2018

von Vinay, K. | Yanamandra, U. | Dogra, S. | +8

7

Outcomes of splenectomy versus cladribine for hairy cell leukemia in resource limited settings

enthalten in: Leukemia & lymphoma | 2014

von Lad, D. | Malhotra, P. | Khadwal, A. | +7

1
[1]